1/x
At the Q1 report, they stressed macroeconomic uncertainty and the fact that marketing budgets were approved later than normal, but ended with a quite optimistic outlook on coming quarters.
1/x
At the Q1 report, they stressed macroeconomic uncertainty and the fact that marketing budgets were approved later than normal, but ended with a quite optimistic outlook on coming quarters.
-Vækst på 24%
-Orderbook vækst 11%
-Scaler EBT kraftigt til 4,1%
-Har 2026 målsætning om mindst 10% EBT margin, de skal vækste en del i 2026 for at nå denne målsætning
-Betaler udbytte på 0,41 kr hvilket svarer til 4,5% yield
-Vækst på 24%
-Orderbook vækst 11%
-Scaler EBT kraftigt til 4,1%
-Har 2026 målsætning om mindst 10% EBT margin, de skal vækste en del i 2026 for at nå denne målsætning
-Betaler udbytte på 0,41 kr hvilket svarer til 4,5% yield
I have initiated a position in the company, seeing an attractive margin of safety with strong parallels to other previously overlooked nanocaps in Scandinavia. Read my take on the case here:
open.substack.com/pub/williamj...
I have initiated a position in the company, seeing an attractive margin of safety with strong parallels to other previously overlooked nanocaps in Scandinavia. Read my take on the case here:
open.substack.com/pub/williamj...